Literature DB >> 409478

A comparative study of two preoperative radiation regimens with cystectomy for bladder cancer.

W F Whitmore, M A Batata, B S Hilaris, G N Reddy, A Unal, M A Ghoneim, H Grabstald, F Chu.   

Abstract

This report surveys the results of two programs of preoperative irradiation with radical cystectomy for bladder cancer in 205 patients. Irradiating the true pelvis to 4000 rads in 4 weeks with radical cystectomy after 6 weeks was implemented in 119 patients (Group 1) from 1959 to 1965; 2000 rads given in 1 week to the true pelvis and radical cystectomy within the following week was implemented in 86 patients (Group 2) from 1966 to 1970. Determinate survival without evidence of recurrence at 5 years was 43% in Group 1 and 42% in Group 2. Mortality with recurrence of bladder cancer in 5 or more years was 44% in group 1 and 42% in group 2. Pelvic complications occurred in 13% of group 1 and 9% of group 2.

Entities:  

Mesh:

Year:  1977        PMID: 409478     DOI: 10.1002/1097-0142(197709)40:3<1077::aid-cncr2820400316>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Combined cisplatin and radiation therapy in patients with invasive bladder cancer.

Authors:  Y Mori; H Ihara; H Shima; K Shimada; M Arima; F Ikoma
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  Supracystic urine diversion in patients with bladder carcinoma treated by cystectomy preceded by "short radiotherapy" (2000 R).

Authors:  A Borkowski; T Krzeski; M Kazoń; D Gajl; M Niemierko; L Rachwał-Sochacka; A Borówka; M Zachwiej; A Miecznikowski
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

3.  Radical cystectomy with or without planned preoperative irradiation in the treatment of bladder cancer.

Authors:  W Barzell; W F Whitmore
Journal:  Urol Res       Date:  1978

4.  Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results.

Authors:  T Kuroiwa; S Naito; K Hasuo; T Kishikawa; K Masuda; J Kumazawa
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.